1997
DOI: 10.1007/s002170050137
|View full text |Cite
|
Sign up to set email alerts
|

On the reaction of glyoxal with proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
46
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(48 citation statements)
references
References 0 publications
2
46
0
Order By: Relevance
“…Among them, N ε -(carboxymethyl)lysine (CML; van de Kerkhof et al , 2004), N ε -(carboxyethyl)lysine (CEL; Zhu et al , 2012), ɛ-(2′-formyl-5′-hydroxymethyl-pyrrolyl)-L-norleucine (pyrraline; Foerster and Henle, 2003), and glyceraldehyde-derived pyridinium (GLAP; Usui et al , 2007) are the best-characterized lysine-derived products. For arginine residues, Schwarzenbolz and coworkers described 1-(4-amino-4-carboxybutyl)-2-imino-5-oxo-imidazolidine (Glarg) formed in the reaction with glyoxal (Schwarzenbolz et al , 1997) and yielding N δ -carboxylethylarginine (CMA) under physiological conditions (Glomb and Lang, 2001). Methylglyoxal forms methylglyoxal-derived hydroimidazolones (MG-Hs) with N δ -(5-methyl-4-oxo-5-hydroimidazolinone-2-yl)-L-ornithine (MG-H1) as the major representative (Henle et al , 1994).…”
Section: Introductionmentioning
confidence: 99%
“…Among them, N ε -(carboxymethyl)lysine (CML; van de Kerkhof et al , 2004), N ε -(carboxyethyl)lysine (CEL; Zhu et al , 2012), ɛ-(2′-formyl-5′-hydroxymethyl-pyrrolyl)-L-norleucine (pyrraline; Foerster and Henle, 2003), and glyceraldehyde-derived pyridinium (GLAP; Usui et al , 2007) are the best-characterized lysine-derived products. For arginine residues, Schwarzenbolz and coworkers described 1-(4-amino-4-carboxybutyl)-2-imino-5-oxo-imidazolidine (Glarg) formed in the reaction with glyoxal (Schwarzenbolz et al , 1997) and yielding N δ -carboxylethylarginine (CMA) under physiological conditions (Glomb and Lang, 2001). Methylglyoxal forms methylglyoxal-derived hydroimidazolones (MG-Hs) with N δ -(5-methyl-4-oxo-5-hydroimidazolinone-2-yl)-L-ornithine (MG-H1) as the major representative (Henle et al , 1994).…”
Section: Introductionmentioning
confidence: 99%
“…Both hyperglycemia and hyperlipidemia may be sources of glycating agents and give rise to increased levels of AGEs and advanced lipoxidation end products (ALEs). Glyoxal is a potent glycating agent formed in both glycation and lipid peroxidation processes and can lead to the formation of the glycation adducts N ε ‐carboxymethyl‐lysine, the hydroimidazolone N δ ‐(5‐hydro‐4‐imidazolon‐2‐yl)ornithine (G‐H1), and N ω ‐carboxymethylarginine 16–20. Methylglyoxal is formed mainly from the degradation of triosephosphates and also by ketone body metabolism and threonine catabolism 21.…”
Section: Introduction: Correcting Diabetic Dyslipidemia and Thiamine mentioning
confidence: 99%
“…Methylglyoxal formation was also found in a model lipid peroxidation system 22. It is a potent glycating agent, forming mainly the hydroimidazolone N δ ‐(5‐hydro‐5‐methyl‐4‐imidazolon‐2‐yl)‐ornithine (MG‐H1) and usually approximately 10‐fold lower amounts of N ε ‐(1‐carboxyethyl)lysine 19,23. The concentrations of glyoxal‐ and methylglyoxal‐derived AGEs were increased in protein extracts of renal glomeruli, retina, and the sciatic nerve of STZ‐induced diabetic rats 19.…”
Section: Introduction: Correcting Diabetic Dyslipidemia and Thiamine mentioning
confidence: 99%
“…It was then synthesized from L-arginine and glyoxal, and other similar glyoxalarginine derivatives were recently characterized [17,18]. ␣-NFC-1, one of the above derivatives, that was formed in vitro by the reaction of glucose or ribose and arginine [18], and have a chemical structure similar to CMA shown in Fig.…”
Section: Discussionmentioning
confidence: 99%